Skip to content

13F-HR filed by Boxer Capital, LLC

Boxer Capital, LLC filed this 13F-HR for the quarter ended 2017-09-30, filed 2017-11-14, with 30 holding rows worth $439,261,000.

Accession
0000950123-17-010901
Filed
2017-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2017

A holdings report, 30 entries on the cover page, a total value of $439,261,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $439,265,000 with VALUE read as thousands by filing date, 13F file number 028-17339. The quarter's positions are built on this report. The resolved quarter.

Other managers

  • included managerAviva Holdings Ltd. 028-17342

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
AVEXIS INC05366U100COM800,000$77,384,000thousands by filing date
BEONE MEDICINES LTD SPONSORED ADS07725L102ADR600,000$62,076,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM500,000$41,200,000thousands by filing date
MACROGENICS INC556099109COM2,200,000$40,656,000thousands by filing date
MEDICINES CO584688105COM900,000$33,336,000thousands by filing date
ESPERION THERAPEUTICS INC NEW COM29664W105Stock500,000$25,060,000thousands by filing date
PTC THERAPEUTICS INC69366J200COM1,250,000$25,013,000thousands by filing date
BLUEPRINT MEDICINES CORP09627Y109COM250,000$17,418,000thousands by filing date
G1 THERAPEUTICS INC3621LQ109COM629,179$15,660,000thousands by filing date
KURA ONCOLOGY INC COM50127T109Stock844,789$12,630,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM1,037,994$12,145,000thousands by filing date
PUMA BIOTECHNOLOGY INC74587V107COMMON STOCK100,000$11,975,000thousands by filing date
LA JOLLA PHARMACEUTICAL CO503459604COM PAR $.0001 2267,500$9,304,000thousands by filing date
CYMABAY THERAPEUTICS INC23257D103COM1,012,986$8,165,000thousands by filing date
ZOGENIX INC.98978L204Common Stock200,000$7,010,000thousands by filing date
REATA PHARMACEUTICALS INC75615P103CL A200,000$6,220,000thousands by filing date
STRONGBRIDGE BIOPHARMA PLCG85347105SHS USD856,900$5,913,000thousands by filing date
GTX INC DEL40052B207COM NEW565,291$4,771,000thousands by filing date
AQUINOX PHARMACEUTICALS INC03842B101COM312,500$4,434,000thousands by filing date
AXOVANT SCIENCES LTDG0750W104COM500,000$3,440,000thousands by filing date
REGULUS THERAPEUTICS INC75915K101COM2,197,802$2,747,000thousands by filing date
BELLEROPHON THERAPEUTICS INC078771102COM1,857,143$2,637,000thousands by filing date
ARADIGM CORP038505400COM NO PAR NEW500,000$2,100,000thousands by filing date
SUNESIS PHARMACEUTICALS INC867328700COM1,025,000$1,989,000thousands by filing date
BARCLAYS BK PLC06746L422IPATH S&P500 VIX50,000$1,960,000thousands by filing date
EIGER BIOPHARMACEUTICALS INC28249U105COM138,331$1,522,000thousands by filing date
SYNDAX PHARMACEUTICALS INC87164F105COM100,000$1,170,000thousands by filing date
NABRIVA THERAPEUTICS AG62957M104SPONSORED ADR86,710$710,000thousands by filing date
ONCONOVA THERAPEUTICS INC68232V116*W EXP 07/11/202308,793$528,000thousands by filing date
ONCONOVA THERAPEUTICS INC COM PAR68232V306Stock241,644$92,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-17-010901this filing2017-11-14acceptance time not in the bulk data set